Answers are grounded in this paper and cite their sources.
Control of societal costs can be addressed through clinician education, value-based guidelines and pathways, formulary restrictions, payment reform, and government regulatory decisions but should not be imposed on patients at the point of decision-making in the cancer clinic.
No takes yet. Share an insight, caveat, or question.
Jeffrey Peppercorn (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: